When BRAFi and HSV were tested in combination in vitro in the BRAF V600E mutant murine melanoma 4434, although both agents were cytotoxic when tested alone (figure 1A), no significant combination effect was seen (figure 1B). The gene discussed is BRAF; the disease is melanoma.